Command Palette

Search for a command to run...

AAREYDRUGS

80.4-1.95%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Aarey Drugs & Pharmaceuticals Ltd. is currently lagging behind its peers in all major financial metrics, indicating a challenging position in the Pharmaceuticals & Drugs sector. While other companies exhibit strong growth and profitability, Aarey demonstrates no revenue growth, zero profitability metrics, and a significant valuation multiple. This highlights an opportunity for improvement or a strategic pivot to enhance its market standing.

Key Points
  • Aarey Drugs has no revenue or profitability metrics, posing a significant risk compared to peers.
  • Sun Pharmaceutical and Dr. Reddy's Laboratories lead in profitability and growth.
  • Cipla Ltd. and Mankind Pharma show promising growth with attractive valuation metrics.
Top Performers
Sun Pharmaceutical Industries Ltd.

Strong revenue growth of 8.42% YoY and a high ROE of 16.13%.

Dr. Reddy's Laboratories Ltd.

Best in class with the highest ROE (21.76%) and a strong EPS growth.

Mankind Pharma Ltd.

Exceptional revenue growth of 18.12% YoY and solid profitability metrics.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.